Clinical reference
Antiemetic · 5-HT3 receptor antagonist · Oncology, Anesthesiology, Radiation Oncology, Pediatrics, Internal Medicine
Granisetron is a selective 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist used for prevention and treatment of chemotherapy-induced, radiation-induced, and postoperative nausea and vomiting. Injection: 1 mg/mL (1, 4 mL); 4 mL multidose vials contain benzyl alcohol. Extended-release prefilled syringe for subcutaneous injection (Sustol): 10 mg/0.4 m…